Concepedia

Lukas Klumpp

LK

18

Publications

589

Citations

14

H-Index

2002

Active since

Affiliations

University of Tübingen(Current)

Goethe University Frankfurt

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology

Heidelberg University

University Children's Hospital Tübingen

Lukas Klumpp is an author at University of Tübingen specializing in medicine, pharmacology, and pharmacokinetics.

ORCID

Top concepts

Publications per year

2002–2023

18

Publications

18

Validation of Dissolution Testing with Biorelevant Media: An OrBiTo Study

James Mann, Jennifer Dressman, Karin M. Rosenblatt et al. · Molecular Pharmaceutics · 2017 · 94 citations

, , +18

BK K+ channel blockade inhibits radiation-induced migration/brain infiltration of glioblastoma cells

Lena Edalat, Benjamin Stegen, Lukas Klumpp et al. · Oncotarget · 2016 · 63 citations · Full text

, , +18

Ca2+-Activated IK K+ Channel Blockade Radiosensitizes Glioblastoma Cells

Benjamin Stegen, Lena Butz, Lukas Klumpp et al. · Molecular Cancer Research · 2015 · 62 citations

Alternating Electric Fields (TTFields) Activate Cav1.2 Channels in Human Glioblastoma Cells

Eric Neuhaus, Lisa Zirjacks, Katrin Ganser et al. · Cancers · 2019 · 61 citations · Full text

Biorelevant dissolution testing of a weak base: Interlaboratory reproducibility and investigation of parameters controlling in vitro precipitation

Philippe Berben, L. J. Ashworth, Stefania Beato et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2019 · 43 citations · Full text

, , +7

Rows per page

1–5 of 18